Paget's disease of the breast differential diagnosis: Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 52: | Line 52: | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Eczema]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Eczema]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | Scalp, face, trunk, postauricular, diaper area and axilla | | align="center" style="background:#F5F5F5;" | Scalp, face, trunk, postauricular, diaper area and axilla | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 123: | Line 123: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref> | ||
|Benign | | align="center" style="background:#F5F5F5;" |Benign | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Delayed-type [[hypersensitivity]] response | * Delayed-type [[hypersensitivity]] response | ||
Line 182: | Line 182: | ||
* Vitamin D deficiency | * Vitamin D deficiency | ||
|- | |- | ||
![[Melanoma|Malignant melanoma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Melanoma|Malignant melanoma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 199: | Line 199: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
![[Bowen’s disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bowen’s disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 216: | Line 216: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
![[Basal cell carcinoma|Superficial basal cell carcinoma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Basal cell carcinoma|Superficial basal cell carcinoma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 233: | Line 233: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
![[Basal cell carcinoma|Pagetoid basal cell carcinoma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Basal cell carcinoma|Pagetoid basal cell carcinoma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 250: | Line 250: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
![[Intraductal papilloma|Benign intraductal papilloma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 267: | Line 267: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
!Pagetoid dyskeratosis | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Pagetoid dyskeratosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 284: | Line 284: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
![[Duct ectasia of breast|Lactiferous duct ectasia]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Duct ectasia of breast|Lactiferous duct ectasia]] | ||
| align="center" style="background:#F5F5F5;" |Benign | | align="center" style="background:#F5F5F5;" |Benign | ||
| align="center" style="background:#F5F5F5;" |* Common among [[perimenopausal]]<nowiki/>women | | align="center" style="background:#F5F5F5;" |* Common among [[perimenopausal]]<nowiki/>women | ||
Line 304: | Line 304: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
!Nipple duct adenoma | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Nipple duct adenoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 321: | Line 321: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
!Benign Toker cell hyperplasia | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign Toker cell hyperplasia | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 338: | Line 338: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
![[Breast abscess]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Breast abscess]] | ||
| align="center" style="background:#F5F5F5;" |Benign | | align="center" style="background:#F5F5F5;" |Benign | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 359: | Line 359: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
![[Mondors disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mondors disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 376: | Line 376: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
![[Mastitis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mastitis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Benign]] | * [[Benign]] | ||
Line 403: | Line 403: | ||
| | | | ||
|- | |- | ||
!Inflammatory Breast Cancer | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Inflammatory Breast Cancer | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | |
Revision as of 16:51, 21 February 2019
Paget's disease of the breast Microchapters |
Differentiating Paget's disease of the breast from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget's disease of the breast differential diagnosis On the Web |
American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis |
Paget's disease of the breast differential diagnosis in the news |
Blogs on Paget's disease of the breast differential diagnosis |
Directions to Hospitals Treating Paget's disease of the breast |
Risk calculators and risk factors for Paget's disease of the breast differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]
Differential Diagnosis
Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]
- Atopic dermatitis
- Chronic contact dermatitis
- Lactiferous duct ectasia
- Chronic eczema
- Psoriasis
- Nipple duct adenoma
- Malignant melanoma
- Bowen’s disease
- Superficial basal cell carcinoma
- Pagetoid basal cell carcinoma
- Benign intraductal papilloma
- Pagetoid dyskeratosis
Category | Diseases | Benign or Malignant | Etiology | Clinical manifestations | Para-clinical findings | Gold Standard | Associated factors | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||||
Lab Findings | Histopathology | ||||||||||||||||
Rash | Nipple Discharge | Erythema | Single/
Multiple |
Involved areas | Mastalgia | Breast Exam | Other | Serum IgE | |||||||||
Eczema | Scalp, face, trunk, postauricular, diaper area and axilla | + | – | + |
|
Nl |
|
Risk factors include
Generalized seborrheic erythroderma in immunodeficient patients |
|||||||||
Skin disorders | Atopic dermatitis | Benign |
|
– | Multiple | + |
|
– |
|
↑ |
|
| |||||
Allergic contact dermatitis[3] | Benign |
|
Erythematous well-demarcated papules | – | May be multiple after 1-2 days of exposure | + | Surrounding the area in contact with the offending agent | + |
|
Nl |
|
| |||||
Psoriasis | Benign |
|
Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales | + | Multiple | + |
|
+ |
|
Nl |
|
Risk factors include
| |||||
Malignant melanoma | |||||||||||||||||
Bowen’s disease | |||||||||||||||||
Superficial basal cell carcinoma | |||||||||||||||||
Pagetoid basal cell carcinoma | |||||||||||||||||
Benign intraductal papilloma | |||||||||||||||||
Pagetoid dyskeratosis | |||||||||||||||||
Lactiferous duct ectasia | Benign | * Common among perimenopausalwomen
|
* Distention of subareolar ducts | Ultrasound:
|
|||||||||||||
Nipple duct adenoma | |||||||||||||||||
Benign Toker cell hyperplasia | |||||||||||||||||
Breast abscess | Benign | + |
|
|
|||||||||||||
Mondors disease | |||||||||||||||||
Mastitis |
|
+ | ± |
|
|
||||||||||||
Inflammatory Breast Cancer |
References
- ↑ 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
- ↑ 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.